Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Ovarian Neoplasms 11 Fallopian Tube Neoplasms 10 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 5 Brenner Tumor 5 Lung Neoplasms 4 Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma 3 Adenocarcinoma of Lung 3 Oropharyngeal Neoplasms 2 Neurotoxicity Syndromes 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Carcinosarcoma 2 Carcinoma, Transitional Cell 2 Vomiting 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Cancer Resectable 1 Pancreatic Adenocarcinoma 1 Pancreas Adenocarcinoma 1 Pain 1 Ovarian Germ Cell Cancer 1

Interventions

Etoposide 3 Cisplatin 3 Bleomycin 3 Carboplatin 2 sodium thiosulfate 1 etoposide phosphate 1 Vinblastine 1 Taxes 1 Surgical Procedures, Operative 1 Restraint, Physical 1 Paclitaxel 1 Ifosfamide 1 Cyproheptadine 1 Congresses as Topic 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ovarian Germ Cell Cancer × Taxes × Clear all

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡